article thumbnail

Shaking the MoneyTree 2012

SoCal Tech Calendar

Thursday, March 1, 2012 -- Please join PwC, the Los Angeles Venture Association, and a distinguished panel of venture capitalists and industry experts for their insight into results of the MoneyTree Report. The MoneyTree Report is a quarterly study of venture capital investment activity in the United States.

Press 124
article thumbnail

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More

Xconomy

Post-marketing studies aim to identify side effects not observed in the first three phases of testing. This week, results of such a study led to the market withdrawal of weight-loss pill lorcaserin (Belviq). When the FDA approved the drug in 2012, the agency was concerned about heart risks.

Study 77
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen Licenses Rights To Multiple Myeloma Drug

socalTECH

The compound is currently in Phase I studies. The two said the drug was originally licensed to Boehringer Ingelheim by Micromet, before Amgen acquired Micromet in 2012. Financial details of the deal were not announced. READ MORE>>.

article thumbnail

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

Xconomy

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme.

San Diego 103
article thumbnail

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

Xconomy

Eisai is withdrawing weight-loss drug lorcaserin after a post-marketing study found a higher incidence of cancer in patients who took the medicine. Lorcaserin was approved in 2012 as a weight management therapy for use in addition to a reduced-calorie diet and exercise. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

LAVA hosts PwC's Shaking the MoneyTree

SoCal Tech Calendar

Thursday, May 24, 2012 -- LAVA hosts PwC's Shaking the MoneyTree. Please join LAVA, PwC and a distinguished panel of industry experts and local VCs for their insights on the results of the Q1 2012 PwC/National Venture Capital Association MoneyTree Report based on data from Thomson Reuters. See [link] (more)

LAVA 113
article thumbnail

New markets emerge for carbon accounting businesses as cities like LA push proposals

TechCrunch LA

Earlier this month, Los Angeles became the latest city to task its various departments with prepping a feasibility study for deploying new software and monitoring technologies to better account for its carbon footprint. Los Angeles has tried to address its carbon footprint in the past, but the efforts weren’t very successful.